Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry
Rheumatology (Oxford). 2024 Sep 28:keae530. doi: 10.1093/rheumatology/keae530. Online ahead of print. ABSTRACT OBJECTIVE: We aimed to gather real-world clinical evidence of detailed disease activity, treatments, …